Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interactions of YHR2402 and YHR2403 in Healthy Volunteers
NCT06623526Phase 1Completed
- Sponsor
- Yuhan
- Start
- Oct 2024
- Primary completion
- Nov 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHR2402 and YHR2403 in acute bronchitis (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve from time 0 to the last measurable concentration and Maximum plasma concentration. Started Oct 2024; status: completed.
02
Drugs
YHR2402YHR2403
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on NCT06623526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06623526.